ABL1 and acute lymphoblastic leukemia: Notably, Ph+ B-ALL was associated with a very poor outcome in both children and adults, with less than 20% long-term survival until the introduction of PTKi capable of inhibiting the oncogenic BCR-ABL tyrosine kinase[36-48] [Table 1].